J. Nelson

发表

Specific selection of deoxycytidine kinase mutants with tritiated deoxyadenosine

J. A. Nelson, T. Chan, J. Nelson, 1995, Biochemical Genetics.

Specific selection of deoxycytidine kinase mutants with tritiated deoxyadenosine

J. A. Nelson, T. Chan, J. Nelson, 1995, Biochemical Genetics.

Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component.

R. Vile, H. Chong, S. Castleden, 1994, Cancer research.

Enhanced transepithelial flux of cimetidine by Madin-Darby canine kidney cells overexpressing human P-glycoprotein.

J. A. Nelson, B. Pan, A. Dutt, 1994, The Journal of pharmacology and experimental therapeutics.

P-glycoprotein and organic cation secretion by the mammalian kidney.

L. A. Heath, J. A. Nelson, A. Dutt, 1994, The Journal of pharmacology and experimental therapeutics.

Renal handling of 2′-deoxyadenosine and adenosine in humans and mice

J. Kuttesch, J. A. Nelson, J. Nelson, 2004, Cancer Chemotherapy and Pharmacology.

THE MECHANISM OF ACTION OF 3‐DEAZAURIDINE IN TUMOR CELLS SENSITIVE AND RESISTANT TO ARABINOSYLCYTOSINE *

F. Schabel, R. W. Brockman, J. A. Nelson, 1975, Annals of the New York Academy of Sciences.

Potentiation of methotrexate toxicity by dipyridamole.

S. Drake, J. A. Nelson, J. Nelson, 1984, Cancer research.

Effects of 6-thiopurines on the transforming activity of bacillus subtilis dexoyribonucleic acid.

B. A. Harris, D. Weigent, J. A. Nelson, 1979, Biochemical pharmacology.

Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabine

W. Plunkett, M. Keating, J. A. Nelson, 1996, Cancer Chemotherapy and Pharmacology.

A transfected cell model for the renal toxin transporter, rOCT2.

J. A. Nelson, B. Pan, D. H. Sweet, 1999, Toxicological sciences : an official journal of the Society of Toxicology.

Consequences of 6-thioguanine incorporation into DNA on polymerase, ligase, and endonuclease reactions.

Y. Ling, K. Beattie, J. A. Nelson, 1992, Molecular pharmacology.

Utilization of 2′-Deoxy-6-thioguanosine 5′-Triphosphate In DNA Synthesis Catalyzed by DNA Polymerase I Klenow Fragment of Escherichia Coli

Y. Ling, D. Farquhar, K. Beattie, 1992 .

Dihydrodiol dehydrogenase in drug resistance and sensitivity of human carcinomas

J. A. Nelson, B. Pan, J. Nelson, 2007, Cancer Chemotherapy and Pharmacology.

Metabolism and mechanisms of action of 9-(tetrahydro-2-furyl)-6-mercaptopurine in Chinese hamster ovary cells.

S. Drake, J. A. Nelson, R. Burns, 1982, Chemico-biological interactions.

Biochemical mechanisms for the synergism between 6-thioguanine and 6-(methylmercapto)purine ribonucleoside in sarcoma 180 cells.

J. A. Nelson, R. Parks, J. Nelson, 1972, Cancer research.

2'-Deoxy-6-thioguanosine 5'-triphosphate as a substrate for purified human DNA polymerases and calf thymus terminal deoxynucleotidyltransferase in vitro.

Y. Cheng, Y. Ling, R. Anderson, 1991, Molecular pharmacology.

Role of organic cation transporters in the renal secretion of nucleosides.

J. A. Nelson, R. Chen, Rong Chen, 2000, Biochemical pharmacology.

Postnatal development of organic cation transport and mdr gene expression in mouse kidney.

M. Kuo, L. Teeter, T. Priebe, 1992, The Journal of pharmacology and experimental therapeutics.

Renal organic cation and nucleoside transport.

Rong Chen, J. Jonker, J. A. Nelson, 2002, Biochemical pharmacology.

Effects of 2-amino-1,3,4-thiadiazole on ribonucleotide pools of leukemia L1210 cells.

J. A. Nelson, L. Bennett, L. Rose, 1976, Cancer research.

Mechanism of action of 2-amino-1,3,4-thiadiazole (NSC 4728).

J. A. Nelson, L. Bennett, L. Rose, 1977, Cancer research.

Selective modulation of antibody response and natural killer cell activity by purine nucleoside analogues.

B. Pan, T. Priebe, M. Nakić, 1988, Cancer research.

Suicide gene therapy using E. coli beta-galactosidase.

Ajit K. Ghosh, D. Farquhar, C. Mullen, 2002, Cancer chemotherapy and pharmacology.

Role of the host in the variable chemotherapeutic response of advanced Ridgway osteogenic sarcoma

J. A. Nelson, J. Hokanson, V. K. Jenkins, 2004, Cancer Chemotherapy and Pharmacology.

Mutagenic consequences of the incorporation of 6-thioguanine into DNA.

D. Farquhar, R. Maldonado-Rodríguez, K. Beattie, 1997, Biochemical pharmacology.

Use of vaccinia, a DNA virus, to study the role of DNA incorporation in the mechanism of action of 6-thioguanine.

S. Drake, J. A. Nelson, P. Carpenter, 1983, Biochemical pharmacology.

Inhibition of hypoxanthine-guanine phosphoribosyl transferase.

J. A. Nelson, A. L. Jadhav, L. Townsend, 1979, Biochemical pharmacology.

6-Thioguanine-induced DNA damage as a determinant of cytotoxicity in cultured Chinese hamster ovary cells.

R. Meyn, N. T. Christie, S. Drake, 1984, Cancer research.

Ouabain-sensitive adenosine triphosphatase from human kidneys.

G. Beathard, J. Fish, A. Remmers, 1975, The Journal of pharmacology and experimental therapeutics.

Formation of 6-thioguanine and 6-mercaptopurine from their 9-alkyl derivatives in mice.

J. A. Nelson, E. Vidale, J. Nelson, 1986, Cancer research.

Renal ouabain-sensitive adenosine triphosphatase activity and Na+ reabsorption.

J. A. Nelson, B. R. Nechay, J. Nelson, 1970, The Journal of pharmacology and experimental therapeutics.

Effects of cardiac glycosides of renal adenosine triphosphatase activity and Na+ reabsorption in dogs.

J. A. Nelson, B. R. Nechay, J. Nelson, 1970, The Journal of pharmacology and experimental therapeutics.

Differentiation induction of human promyelocytic leukemia cells by 10-hydroxycamptothecin, a DNA topoisomerase I inhibitor.

Y. Ling, M. Tseng, J. A. Nelson, 1991, Differentiation; research in biological diversity.

Analysis of methotrexate in human plasma by high-pressure liquid chromatography with fluorescence detection.

W. J. Decker, B. A. Harris, D. Farquhar, 1977, Cancer research.